Evidence map›Paper›PMID 35263349›Full record

ArticlePloS one2022

PlexProbes enhance qPCR multiplexing by discriminating multiple targets in each fluorescent channel.

Nicole Hasick, Ryung Rae Kim, Yin Xu, Simon Bone, Andrea Lawrence, Claire Gibbs, Nathan Danckert, Alison Todd

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Nicole HasickSpeeDx Pty Ltd, Eveleigh, New South Wales, Australia.ORCID 0000-0002-6770-3152
Ryung Rae KimSpeeDx Pty Ltd, Eveleigh, New South Wales, Australia.ORCID 0000-0003-3810-9514
Yin XuSpeeDx Pty Ltd, Eveleigh, New South Wales, Australia.
Simon BoneSpeeDx Pty Ltd, Eveleigh, New South Wales, Australia.
Andrea LawrenceSpeeDx Pty Ltd, Eveleigh, New South Wales, Australia.
Claire GibbsSpeeDx Pty Ltd, Eveleigh, New South Wales, Australia.
Nathan DanckertSpeeDx Pty Ltd, Eveleigh, New South Wales, Australia.ORCID 0000-0001-5416-7971
Alison ToddSpeeDx Pty Ltd, Eveleigh, New South Wales, Australia.
The University of Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The probe technology described in this paper facilitates detection and discrimination of multiple targets in a single fluorescent channel during PCR. This provides a strategy for doubling the number of targets that can be analysed simultaneously on existing PCR instruments. These probes are referred to as PlexProbes and produce fluorescence that can be switched 'on' or 'off' in the presence of target by manipulating the temperature. During PCR, fluorescence can be measured at multiple temperatures allowing discrimination of specific targets at defined temperatures. In a single fluorescent channel, a model duplex assay allowed either real-time or endpoint detection of Chlamydia trachomatis (CT) at 52°C and end-point detection of Neisseria gonorrhoeae (GC) at 74°C. Using this model system, as few as 40 copies of each specific target could be detected as single infection or co-infection, regardless of the presence or absence of the other target. A PlexProbe prototype assay for sexually transmitted infections (PP-STI) which simultaneously enables detection and differentiation of six targets using only three fluorescent channels was then constructed and evaluated. The PP-STI assay detects GC (2 gene targets), CT, Mycoplasma genitalium (MG), Trichomonas vaginalis (TV) and an internal control (IC). To evaluate assay performance, a panel of archived clinical samples (n = 337) were analysed using PP-STI and results compared to those obtained with a commercially available diagnostic assay. The overall agreement between results obtained with the PP-STI assay and the reference test was greater than 99.5%. PlexProbes offer a method of detecting more targets from a single diagnostic test, empowering physicians to make evidence-based treatment decisions while conserving time, labour, sample volume and reagent costs.

Indexed as

Chlamydia InfectionsGonorrheaMycoplasma genitaliumMycoplasma InfectionsSexually Transmitted DiseasesTrichomonas vaginalisChlamydia trachomatisHumansNeisseria gonorrhoeaeReal-Time Polymerase Chain Reaction

Identifiers

PMID35263349
PMCPMC8906580
OpenAlexW4220895057

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.